Andreana Foresta

581 total citations
10 papers, 105 citations indexed

About

Andreana Foresta is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Neurology. According to data from OpenAlex, Andreana Foresta has authored 10 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Infectious Diseases and 3 papers in Neurology. Recurrent topics in Andreana Foresta's work include Diabetes Treatment and Management (4 papers), COVID-19 Clinical Research Studies (3 papers) and Long-Term Effects of COVID-19 (3 papers). Andreana Foresta is often cited by papers focused on Diabetes Treatment and Management (4 papers), COVID-19 Clinical Research Studies (3 papers) and Long-Term Effects of COVID-19 (3 papers). Andreana Foresta collaborates with scholars based in Italy, Denmark and United Kingdom. Andreana Foresta's co-authors include Marta Baviera, Maria Carla Roncaglioni, Ida Fortino, Mauro Tettamanti, Stefano Genovese, Luisa Ojeda‐Fernández, Giancarlo Marenzi, Nicola Cosentino, Irene Caruso and Francesco Giorgino and has published in prestigious journals such as Diabetes Obesity and Metabolism, Diabetes Research and Clinical Practice and Clinical Therapeutics.

In The Last Decade

Andreana Foresta

9 papers receiving 103 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreana Foresta Italy 6 64 37 26 18 15 10 105
Noelia Castellana Argentina 4 74 1.2× 36 1.0× 45 1.7× 9 0.5× 23 1.5× 12 157
Charlotte Gibbs Norway 5 59 0.9× 50 1.4× 21 0.8× 4 0.2× 9 0.6× 9 123
Takuya Haraguchi Japan 5 100 1.6× 10 0.3× 44 1.7× 12 0.7× 34 2.3× 10 136
Carmina Oltra Spain 5 62 1.0× 27 0.7× 25 1.0× 28 1.6× 22 1.5× 9 143
Ahmed Salem United Kingdom 5 85 1.3× 24 0.6× 44 1.7× 5 0.3× 25 1.7× 16 160
Apexa Kuverji United Kingdom 4 63 1.0× 4 0.1× 32 1.2× 22 1.2× 14 0.9× 5 107
Ulf Landmesser Germany 6 9 0.1× 33 0.9× 24 0.9× 11 0.6× 12 0.8× 14 95
J Skrha Czechia 5 67 1.0× 19 0.5× 16 0.6× 67 3.7× 27 1.8× 8 155
A Ioan Spain 4 15 0.2× 49 1.3× 13 0.5× 20 1.1× 51 3.4× 10 143
Jozica Šikić Croatia 6 17 0.3× 72 1.9× 26 1.0× 5 0.3× 26 1.7× 18 110

Countries citing papers authored by Andreana Foresta

Since Specialization
Citations

This map shows the geographic impact of Andreana Foresta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreana Foresta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreana Foresta more than expected).

Fields of papers citing papers by Andreana Foresta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreana Foresta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreana Foresta. The network helps show where Andreana Foresta may publish in the future.

Co-authorship network of co-authors of Andreana Foresta

This figure shows the co-authorship network connecting the top 25 collaborators of Andreana Foresta. A scholar is included among the top collaborators of Andreana Foresta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreana Foresta. Andreana Foresta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Foresta, Andreana, G Torrigiani, Maria Carla Roncaglioni, et al.. (2024). Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study. Drugs & Aging. 41(3). 239–249. 5 indexed citations
2.
Foresta, Andreana, Luisa Ojeda‐Fernández, Mauro Tettamanti, et al.. (2024). Prevalence and Predictors of Post-Acute COVID-19 Symptoms in Italian Primary Care Patients. Journal of Primary Care & Community Health. 15. 4277842524–4277842524.
3.
Conti, Maria Vittoria, Ilaria Ardoino, Andreana Foresta, et al.. (2024). Multidimensional School-Based and Family-Involved Interventions to Promote a Healthy and Sustainable Lifestyle (LIVELY) for Childhood Obesity Prevention: Study Protocol. JMIR Research Protocols. 13. e57509–e57509. 3 indexed citations
4.
Ojeda‐Fernández, Luisa, Marta Baviera, Andreana Foresta, et al.. (2023). Impact of first and second/third wave of COVID-19 pandemic on post-acute cardiovascular outcomes in Lombardy. Frontiers in Cardiovascular Medicine. 10. 1244002–1244002. 1 indexed citations
5.
Foresta, Andreana, Luisa Ojeda‐Fernández, Maria Carla Roncaglioni, et al.. (2023). Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes. Clinical Therapeutics. 45(4). e115–e126. 6 indexed citations
6.
Foresta, Andreana, Elena Succurro, Marta Baviera, et al.. (2023). Prescribing trends of glucose-lowering drugs in older adults from 2010 to 2021: A population-based study of Northern Italy. Diabetes Research and Clinical Practice. 202. 110742–110742. 12 indexed citations
7.
Ojeda‐Fernández, Luisa, Andreana Foresta, Mauro Tettamanti, et al.. (2022). Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID ‐19 patients with diabetes: A population‐based study in Lombardy. Diabetes Obesity and Metabolism. 24(5). 891–898. 16 indexed citations
8.
Baviera, Marta, Stefano Genovese, Nicola Cosentino, et al.. (2022). Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction. Cardiovascular Diabetology. 21(1). 223–223. 23 indexed citations
9.
Baviera, Marta, Andreana Foresta, Maria Carla Roncaglioni, et al.. (2022). Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study. Cardiovascular Diabetology. 21(1). 162–162. 33 indexed citations
10.
Proietti, Marco, Irene Marzona, Mauro Tettamanti, et al.. (2020). Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 7(FI1). f84–f92. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noelia Castellana Breakdown of academic impact, for papers by Charlotte Gibbs Breakdown of academic impact, for papers by Takuya Haraguchi Breakdown of academic impact, for papers by Carmina Oltra Breakdown of academic impact, for papers by Ahmed Salem Breakdown of academic impact, for papers by Apexa Kuverji Breakdown of academic impact, for papers by Ulf Landmesser Breakdown of academic impact, for papers by J Skrha Breakdown of academic impact, for papers by A Ioan Breakdown of academic impact, for papers by Jozica Šikić
Rankless by CCL
2026